600211.SS
600211.SS
CNE000000ZW7
TIBET RHODIOLA PHARMACEUTICAL H
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 2.981.538.230 2.806.713.296
6.2%
Cost of Revenue 172.474.863 162.296.561
6.3%
Gross Profit 2.809.063.367 2.644.416.735
6.2%
1.839.152.265 1.528.790.115
20.3%
Operating Income 969.911.102 1.115.626.619
13.1%
Pretax Income 1.040.617.869 1.152.084.060
9.7%
Net Income Common Stockholders 937.931.435 1.051.288.308
10.8%
-- --
--
-- --
--
ende